Novartis Joins hands with Medicines Co. The Cholesterol Drug Maker for $ 9.7 Billion

Novartis buy Medicines Company for $9.7 billion The cholesterol drug
maker, Medicines Co. (MDCO) hit a record high in the stock market on
Monday after the  $9.7 billion acquisition of the Medicines Company by
Swiss pharmaceutical giant Novartis announced Sunday. MDCO is into
developing a cholesterol drug Inclisiran, a small interfering RNA
therapy. Novartis agreed to […]

The post Novartis Joins hands with Medicines Co. The Cholesterol Drug
Maker for $ 9.7 Billion appeared first on Rasayanika .

https://www.rasayanika.com/2019/11/26/novartis-buy-medicines-company-for-9-7-billion-shares-hit-record-high/

News